BlueRock’s Cell+Gene platform harnesses the power of cells for new medicines across Neurology, Cardiology and Autoimmunity. BlueRock’s cell differentiation technology recapitulates the cell’s developmental biology to produce native cell therapies, which can be further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. The company was founded in 2016 by Versant Ventures and capitalized with one of the largest-ever Series A financings in biotech history by Bayer AG and Versant.
BlueRock’s culture is defined by scientific innovation, the highest ethical standards and an urgency to bring regenerative medicines to all who would benefit. The company is expanding staff at all locations. Contact us to learn about rewarding career opportunities in New York, Cambridge, and Toronto.
BlueRock science and cellular medicines are based on harnessing the power of the induced pluripotent stem cell as a manufacturing platform. Using this Nobel Prize winning technology, the company can manufacture virtually unlimited quantities of pure healthy cells, for use as therapeutics.
Contact Us
BlueRock is expanding staff in its New York, Cambridge, and Toronto locations. Contact us to learn about our rewarding career opportunities.
Toronto, ON
BlueRock Toronto
MaRS Discovery District
101 College Street, East Tower, 15-701 Toronto, ON
M5G 1L7, Canada
New York, NY
BlueRock New York
Alexandria Center for Life Science
450 E 29th Street, Suite 504
New York, NY 10016, USA
Cambridge, MA
BlueRock Corporate Headquarters
1 Broadway
Cambridge, MA 02142, USA